Novel small molecular compound 2JY-OBZ4 alleviates AD pathology in cell models via regulating multiple targets

Qian Guo(Nantong University), Honglian Li(Huazhong University of Science and Technology)

Aging

October 12, 2022

10.18632/aging.204336

Cited by 7

Related Papers

Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.

|PubMed|2009|32

Immune checkpoint inhibitor-induced pure red cell aplasia: Case series and large‐scale pharmacovigilance analysis

|International Immunopharmacology|2022|15

Immune checkpoint inhibitor-induced aplastic anaemia: Case series and large-scale pharmacovigilance analysis

|Frontiers in Pharmacology|2023|13

Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naïve Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial

|Blood|2022|3

Low-Dose CT Screening

|CHEST Journal|2026|0